Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,625 across all filing types
Latest filing 2020-04-02 Share Issue/Capital Cha…
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movement in Securities for the month ended 31 March 2020
Share Issue/Capital Change Classification · 95% confidence The document is a detailed monthly report on movements in securities, specifically focusing on changes in authorised and issued share capital, share options, warrants, convertibles, and other share-related activities for the month ended 31/3/2020. It is addressed to the Hong Kong Exchanges and Clearing Limited, indicating a regulatory filing related to share capital movements. The content includes tables of share counts, par values, and confirmations about compliance with listing rules. There is no indication that this is an announcement of a report or a summary; rather, it is a detailed regulatory disclosure of share capital changes. This fits the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes.
2020-04-02 English
PRELIMINARY ANNOUNCEMENT OF UNAUDITED ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2019
Annual Report Classification · 95% confidence The document is a preliminary announcement of unaudited annual results for the year ended 31 December 2019 by Overseas Chinese Town (Asia) Holdings Limited. It contains detailed consolidated financial statements including profit or loss, comprehensive income, financial position, notes on accounting policies, segment reporting, and other financial data. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The content includes actual financial data and analysis for the full fiscal year, consistent with an Annual Report. The document is not merely an announcement of report availability, nor is it a certification or a short summary. Therefore, it fits the definition of an Annual Report (10-K). FY 2019
2020-03-31 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is a short announcement from the board of directors stating the date of a board meeting to consider and approve the unaudited final results for the year ended 31 December 2019 and the payment of a final dividend. It does not contain any financial data or the actual results, but merely announces the upcoming meeting and its agenda. The document length is only 1481 characters, which is quite short and fits the pattern of an announcement rather than a full report. According to the 'Menu vs Meal' rule, this is an announcement about a report to be released, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for such announcements that do not fit other specific categories.
2020-03-17 English
DISCLOSEABLE TRANSACTION LIMITED PARTNERSHIP AGREEMENT
Capital/Financing Update Classification · 95% confidence The document is an announcement by Overseas Chinese Town (Asia) Holdings Limited regarding a discloseable transaction involving a Limited Partnership Agreement. It details the terms of the partnership, capital contributions, management, profit distribution, and other related information. The announcement references compliance with the Listing Rules and the nature of the transaction as a discloseable transaction. There is no indication that this is a full financial report, audit report, earnings release, or other types of filings such as AGM materials or call transcripts. The document is a regulatory announcement about a capital investment transaction and partnership formation, which fits best under Capital/Financing Update (CAP). The document length is substantial and contains detailed transaction information, not merely a brief notice or report publication announcement. Therefore, the classification is CAP with high confidence.
2020-03-06 English
Monthly Return of Equity Issuer on Movement in Securities for the month ended 29 February 2020
Share Issue/Capital Change Classification · 95% confidence The document is a detailed monthly report on movements in securities, including authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. It is addressed to the Hong Kong Exchanges and Clearing Limited and includes confirmations related to securities issuance and compliance with listing rules. The content focuses on changes in share capital and securities movements rather than financial performance, management changes, or legal matters. It is not a full financial report, earnings release, or management discussion. The document is a regulatory disclosure about share capital movements and securities issuance, fitting the category of Share Issue/Capital Change announcements.
2020-03-03 English
Monthly Return of Equity Issuer on Movement in Securities for the month ended 31 January 2020
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related activities for the month ended 31/1/2020. The content focuses on share capital changes and related confirmations, typical of regulatory filings required by stock exchanges to report share capital movements. It does not contain financial statements, earnings data, management discussion, or audit information. It is not a report publication announcement since it contains substantive data. The document fits best under 'Regulatory Filings' (RNS) as it is a regulatory compliance document reporting share capital movements to the exchange, not a capital/financing update announcement or a direct share issue announcement. Therefore, the classification is RNS with high confidence.
2020-02-05 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.